Related Experiment Video
Updated: Apr 16, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
State selection in Markov models for panel data with application to psoriatic arthritis
Howard H Z Thom1, Christopher H Jackson2, Daniel Commenges3
1School of Social and Community Medicine, Bristol, U.K.
Comparing disease progression models can be challenging due to varying states. This study introduces a new method using modified Akaike
Area of Science:
- Biostatistics
- Epidemiology
- Health Outcomes Research
Background:
- Continuous-time Markov multistate models are vital for analyzing disease progression and treatment effects.
- Defining disease states and categorizations within these models presents significant uncertainty.
- Different model categorizations can lead to varied conclusions regarding covariate effects and event times.
Purpose of the Study:
- To address the challenge of comparing multistate models with different categorizations and information scales.
- To adapt and apply modified Akaike's and cross-validation criteria for comparing the predictive performance of these models.
- To enable robust model comparison when standard likelihood-based methods are not applicable.
Main Methods:
- Adapted a modified Akaike's criterion and a cross-validatory criterion to compare models based on shared information.
- Utilized Hidden Markov models for implementing the comparison criteria.
- Applied the methodology to panel data, specifically analyzing the Health Assessment Questionnaire score in psoriatic arthritis.
Main Results:
- Developed a method to compare multistate models with differing structures and information content.
- Demonstrated the applicability of the adapted criteria for models fitted to panel data.
- The procedure is implementable within the R package 'msm'.
Conclusions:
- The proposed criteria effectively compare the predictive abilities of multistate models, even with different state definitions.
- This approach provides a reliable method for selecting appropriate models in disease progression studies.
- Facilitates more accurate understanding of disease dynamics and treatment impacts in complex health conditions.
Related Concept Videos
Mechanistic Models: Compartment Models in Individual and Population Analysis
The JAK-STAT Signaling Pathway
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Statistical Methods for Analyzing Epidemiological Data

